Pharma Journalist - Page 23 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Grants Orphan Status to Cellenkos’ CK0804 in Myelofibrosis

Santhera Licenses AGAMREE to Nxera in Key Asia-Pacific Markets

Lilly Trial Shows Dual Therapy Benefits in Psoriatic Arthritis Patients

Amgen Acquires Dark Blue to Advance Novel AML Treatments

FDA Approves New 2-Gram Fibryga Kit for Bleeding Care

GSK Phase III Trials Show Promise for Chronic Hepatitis B Therapy

Takeda Expands Entyvio Options Through Halozyme Technology Partnership

Lilly to Acquire Ventyx in $1.2 Billion Inflammation Deal

Day One Completes Acquisition of Mersana Therapeutics

FDA Grants Expedited Status to Protara’s Pediatric Lymphatic Malformation Therapy